| 2026-05-25 |
详情>>
内部人交易：
Kwong Connie H.共交易2笔
|
| 2026-04-23 |
详情>>
股本变动：
变动后总股本8954.60万股
|
| 2026-04-23 |
详情>>
业绩披露：
2026年一季报每股收益-0.52美元,归母净利润-4513.7万美元,同比去年增长9.20%
|
| 2026-04-23 |
财报披露：
美东时间 2026-04-23 盘后发布财报
|
| 2026-04-02 |
股东大会：
将于2026-05-20召开股东大会
会议内容 ▼▲
- 1.To elect the two nominees for Class II director named in the proxy statement, each to hold office until our 2029 annual meeting of stockholders and until their respective successors are duly elected and qualified.
2.To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2025, as set forth in the proxy statement.
3.To ratify the appointment by the audit committee of our board of directors of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
4.To approve an amendment and restatement of the MaxLinear, Inc. Amended and Restated 2010 Equity Incentive Plan, including approval of a new ten-year term and an increase in the number of shares reserved thereunder by 3,204,107. If approved, the Inducement Plan would be terminated, and the 3,127,896 shares available as of March 23, 2026 under the Inducement Plan would not be granted under the Inducement Plan.
5.To approve an amendment and restatement of the MaxLinear, Inc. 2010 Employee Stock Purchase Plan to approve a new term.
6.To transact any other business that may properly come before the 2026 annual meeting or any postponement or adjournment thereof.
|
| 2026-01-29 |
详情>>
业绩披露：
2025年年报每股收益-1.58美元,归母净利润-1.37亿美元,同比去年增长44.26%
|
| 2026-01-29 |
详情>>
业绩披露：
2023年年报每股收益-0.91美元,归母净利润-7314.7万美元,同比去年增长-158.5%
|
| 2025-10-23 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.41美元,归母净利润-1.22亿美元,同比去年增长35.00%
|
| 2025-07-23 |
详情>>
业绩披露：
2025年中报每股收益-0.89美元,归母净利润-7629.9万美元,同比去年增长31.62%
|
| 2025-04-23 |
详情>>
业绩披露：
2025年一季报每股收益-0.58美元,归母净利润-4971.3万美元,同比去年增长31.25%
|
| 2025-04-07 |
股东大会：
将于2025-05-20召开股东大会
会议内容 ▼▲
- 1.Elect the nominee for Class I director named in the proxy statement, to hold office until our 2028 annual meeting of stockholders and until his successor is duly elected and qualified;
2.Approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2024, as set forth in the proxy statement;
3.Ratify the appointment by the audit committee of our board of directors of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
4.Approve an amendment of the MaxLinear, Inc. Amended and Restated 2010 Equity Incentive Plan to increase the number of shares reserved thereunder by 3,657,565, as amended, the “Amended Plan”.
|
| 2025-01-29 |
详情>>
业绩披露：
2024年年报每股收益-2.93美元,归母净利润-2.45亿美元,同比去年增长-235.21%
|
| 2025-01-29 |
详情>>
业绩披露：
2022年年报每股收益1.60美元,归母净利润1.25亿美元,同比去年增长197.93%
|
| 2024-10-23 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-2.25美元,归母净利润-1.87亿美元,同比去年增长-440.77%
|
| 2024-07-24 |
详情>>
业绩披露：
2024年中报每股收益-1.35美元,归母净利润-1.12亿美元,同比去年增长-2253.13%
|
| 2024-04-24 |
详情>>
业绩披露：
2024年一季报每股收益-0.88美元,归母净利润-7230.9万美元,同比去年增长-858.51%
|
| 2024-04-04 |
股东大会：
将于2024-05-23召开股东大会
会议内容 ▼▲
- 1.To elect the three nominees for Class III director named in the proxy statement, each to hold office until our 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified.
2.To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2023, as set forth in the proxy statement.
3.To ratify the appointment by the audit committee of our board of directors of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
4.To transact any other business that may properly come before the 2024 annual meeting or any postponement or adjournment thereof.
|
| 2023-07-27 |
复牌提示：
2023-07-26 15:01:53 停牌，复牌日期 2023-07-26 15:45:00
|
| 2023-04-07 |
股东大会：
将于2023-05-10召开股东大会
会议内容 ▼▲
- 1.To elect the three nominees for Class II director named in the proxy statement, each to hold office until our 2026 annual meeting of stockholders and until their respective successors are duly elected and qualified.
2.To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2022, as set forth in the proxy statement.
3.To approve, on a non-binding advisory basis, the frequency of future stockholder votes on named executive officer compensation.
4.To ratify the appointment by the audit committee of our board of directors of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.
5.To approve an amendment to our amended and restated certificate of incorporation to reflect Delaware law provisions regarding officer exculpation.
6.To transact any other business that may properly come before the 2023 annual meeting or any postponement or adjournment thereof.
|
| 2022-04-28 |
股东大会：
将于2022-05-26召开股东大会
会议内容 ▼▲
- 1.To elect the two nominees for Class I director named in the proxy statement, each to hold office until our 2025 annual meeting of stockholders and until their respective successors are duly elected and qualified.
2.To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2021, as set forth in the proxy statement.
3.To ratify the appointment by the audit committee of our board of directors of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.
4.To transact any other business that may properly come before the 2022 annual meeting or any postponement or adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-13 |
股东大会：
将于2021-05-12召开股东大会
会议内容 ▼▲
- 1.elect the three nominees for Class III director named in the proxy statement, each to hold office until our 2024 annual meeting of stockholders and until their respective successors are duly elected and qualified;
2.approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2020, as set forth in the proxy statement;
3.ratify the appointment by the audit committee of our board of directors of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021.
|
| 2020-04-28 |
股东大会：
将于2020-06-08召开股东大会
会议内容 ▼▲
- 1.To elect the three nominees for Class II director named in the proxy statement, each to hold office until our 2023 annual meeting of stockholders and until their respective successors are duly elected and qualified.
2.To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2019, as set forth in the proxy statement.
3.To ratify the appointment by the audit committee of our board of directors of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020.
4.To transact any other business that may properly come before the 2020 annual meeting or any postponement or adjournment thereof.
|
| 2019-04-04 |
股东大会：
将于2019-05-09召开股东大会
会议内容 ▼▲
- 1.To elect the two nominees for Class I director named in the proxy statement, each to hold office until our 2022 annual meeting of stockholders and until their respective successors are duly elected and qualified.ve officers for the year ended December 31, 2018, as set forth in the proxy statement.
2.To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2018, as set forth in the proxy statement.
3.To ratify the appointment by the audit committee of our board of directors of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019.
4.To transact any other business that may properly come before the 2019 annual meeting or any postponement or adjournment thereof.
|
| 2018-04-20 |
股东大会：
将于2018-05-25召开股东大会
会议内容 ▼▲
- 1.To elect the two nominees for Class III director named in the proxy statement, each to hold office until our 2021 annual meeting of stockholders and until their respective successors are duly elected and qualified.
2.To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2017, as set forth in the proxy statement.
3.To ratify the appointment by the audit committee of our board of directors of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018.
4.To transact any other business that may properly come before the 2018 annual meeting or any postponement or adjournment thereof.
|
| 2017-04-20 |
股东大会：
将于2017-05-24召开股东大会
会议内容 ▼▲
- 1.elect the two nominees for Class II director named in the proxy statement, each to hold office until our 2020 annual meeting of stockholders and until their respective successors are duly elected and qualified;
2.approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2016, as set forth in the proxy statement;
3.approve, on an advisory basis, the frequency of future stockholder votes on executive compensation;
4.ratify the appointment by the audit committee of our board of directors of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017.
|
| 2016-06-30 |
股东大会：
将于2016-08-10召开股东大会
会议内容 ▼▲
- 1. To elect the two nominees for Class I director named in the proxy statement to be elected by the holders of our Class A common stock and Class B common stock, voting together as a single class, to hold office until our 2019 annual meeting of stockholders and until their respective successors are duly elected and qualified.
2. To approve our Amended and Restated 2010 Equity Incentive Plan, including approval of the material terms of the Amended and Restated 2010 Equity Incentive Plan for purposes of complying with Section 162(m) of the Internal Revenue Code of 1986, as amended.
3. To approve an amendment to our 2010 Employee Stock Purchase Plan to approve a new ten-year term for the 2010 Employee Stock Purchase Plan.
4. To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2015, as set forth in the proxy statement.
5. To ratify the appointment by the audit committee of our board of directors of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016.
6. To transact any other business that may properly come before the 2016 annual meeting or any postponement or adjournment thereof.
|